Research shows that VR can reduce anxiety and stress, which could also lead to a reduction in blood pressure. If VR can lower blood pressure in patients with hypertension, this would be a cost-effective solution. The VRelax glasses have recently been used within Bergman. In this study we want to investigate the effect of this approach on the blood pressure of patients and, among other things, see whether this allowed the operations to continue.

Ongoing research.

Cognitive functioning decreases in psychiatric illness, especially in older adults with schizophrenia, and there is little research into this. This 8-month study in geriatric psychiatry shows that VRelax offers positive experiences and relaxation for patients, with reduction of tension and stress and interest in further user-friendliness, although long-term effects are still unknown.

In forensic psychiatric care, where patients are cared for under compulsory laws and suffer from serious mental illnesses, VRelax can serve as a tool by providing an alternative environment. Qualitative interviews with 15 staff members show that VRelax can improve mood, stress, sleep and depression, relieve anxiety and aggressiveness, and contribute to patient-centered care, making it a valuable addition to healthcare provision.

Pilot VRelax for employees as a 'short mental break' 

The pilot resulted in a significant stress reduction, with a 39% drop in stress levels after using the VR glasses. This initiative is part of Philips' focus on health and well-being in the workplace. This is consistent with previous scientific studies.

Over the past year, COVID-19 caused increasing workload and higher absenteeism, with more burnout complaints among employees. In a pilot study at Mentrum Reigersbos, 30 employees used the new VRelax VR glasses, which led to reduced stress and positive experiences with the user-friendliness, and indicated that VRelax has potential to reduce work-related stress and improve mental health.

The study examines the effects of VRelax, virtual reality glasses with scent technology, on stress reduction in elderly people with dementia. Results show that VRelax effectively reduces stress and misunderstood behavior in this target group, as measured by blood pressure, behavioral observations and interviews.

The aim of the study is to determine whether VRelax is an effective, user-friendly care technology to reduce negative moods, emotions and withdrawal complaints in Johannesbos Detox, and thus minimize the risk of relapse and make detoxification more humane. The results show that VRelax is effective in reducing cravings, tension, sadness and anxiety, making it recommended for use with Johannesbos Detox, although alternative interventions for home use are also important.

View article 1 View article 2

In the Intensive Treatment Clinic of Tactus Addiction Care, VRelax has been used since January 2021 to help patients with substance use and psychiatric problems relax. Qualitative research shows that patients experience less tension and pulling when using VRelax, which suggests that it is useful to continue using VRelax and further investigate it in other Tactus clinical settings.

This study investigates the use of VRelax, a VR aid, in treating behavioral problems in dementia patients. VRelax offers immersive natural environments, aimed at reducing stress and improving behavior. Using 11 dementia patients, the study measured emotional responses and neuropsychiatric symptoms before and after VR sessions. Results indicate increased pleasure and well-being, with some side effects such as anxiety and dizziness.